查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012855

生物安全柜市场：按等级、类型、最终用户和应用划分－2026-2032年全球市场预测

Biological Safety Cabinet Market by Class, Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物安全柜市场价值将达到 5.3287 亿美元，到 2026 年将成长至 5.7468 亿美元，到 2032 年将达到 9.6632 亿美元，年复合成长率为 8.87%。

主要市场统计数据
基准年 2025 5.3287亿美元
预计年份：2026年 5.7468亿美元
预测年份 2032 9.6632亿美元
复合年增长率 (%) 8.87%

简明扼要、权威地介绍了当前生物安全柜的优先事项，包括实验室环境中的隔离、合规性和运作弹性。

生物安全柜仍然是实验室处理传染性病原体、细胞培养和高灵敏度诊断检测的基础基础设施。现代实验室需要能够提供稳定防护性能、保障使用者安全和洁净工作环境的解决方案，同时也要简化工作流程并确保符合法规要求。生物安全柜技术的进步，包括改进的气流管理、整合监控以及支援严格消毒的材料，正在改变实验室对生命週期成本和营运风险的认知。

技术整合、更严格的法规和不断发展的实验室实践如何重新定义生物安全柜的性能预期和采购标准。

生物安全柜产业正经历一场变革，其驱动力包括技术创新、法规演进和实验室操作规范的改变。新一代生物安全柜整合了感测器网络，可即时监测气流异常和过滤器性能，从而实现预测性维护并减少意外停机时间。这种向互联设备的转变与实验室数位化进程相契合，使实验室能够将生物安全柜遥测技术与环境监测平台和品管系统整合。

量化 2025 年美国关税调整对生物安全设备采购、库存策略和供应商关係的营运和采购外溢效应。

2025年美国关税调整对采购生物安全柜及相关组件的机构的筹资策略、供应链设计和供应商谈判动态产生了实际的影响。部分进口商品关税的提高推高了从受影响地区采购的生物安全柜及其零件的总到岸成本，迫使采购团队重新评估采购地点和合约条款。为此，许多采购方与供应商重新谈判合同，争取包含运费、延长保固期或捆绑式维护计划等条款，以减轻成本影响。

详细的細項分析揭示了类别、类型、最终用户和应用程式之间的相互依赖性如何决定技术规格、采购偏好和支援需求。

详细的細項分析揭示了不同等级、类型、最终用户和应用场景的机柜在规格、采购行为和支援需求方面存在显着差异。基于等级，我们检视了I级、II级和III级机柜的整体情况，其中II级机柜又细分为A1、A2、B1和B2。每个等级都有其独特的密闭性、气流和排气要求，这些要求决定了安装和认证要求。基于类型，机柜分为水平和垂直两种，这些类型的机柜在人体工学、面积和工作流程适用性方面会影响使用者偏好和实验室布局决策。

影响美洲、欧洲、中东和非洲以及亚太地区采购行为和服务期望的区域趋势和服务网络策略。

区域趋势以不同的方式影响供应链、标准解读和客户期望。在美洲，终端使用者尤其重视服务应对力、与临床工作流程的整合以及对联邦和州安全法规的遵守，这推动了对本地服务网路和易于获取的耗材的需求。在欧洲、中东和非洲，法规环境的多样性和资源状况的差异促使供应商提供广泛的产品、灵活的资金筹措模式和全面的验证文件，以支援不同的认证流程。

关键公司和竞争对手讯息，展示了服务模式、产品整合和生命週期支援如何推动生物安全解决方案的买家偏好和供应商差异化。

在生物安全柜市场，竞争优势越来越依赖卓越的服务、验证支援和产品生命週期管理。领先的製造商和经销商透过认证的现场服务网络、支援预测性维护计划的数位化服务平台以及便于受监管客户部署的综合验证方案包来脱颖而出。与过滤器製造商、感测器供应商和环境监控平台供应商建立策略伙伴关係，使供应商能够提供整合解决方案而非单一设备，从而提高机构客户的忠诚度。

为製造商和机构负责人提供切实可行的建议，以增强服务弹性、整合服务和提供培训，同时降低整体拥有成本 (TCO) 和合规负担。

行业领导企业可以透过优先考虑服务弹性、互通性和客户教育来巩固其市场领导地位。投资建造区域服务中心和培训认证现场技术人员可以缩短平均维修时间，并在受法规环境中增强客户信心。同样重要的是开发开放式整合框架和应用程式介面 (API)，将机柜遥测资料与实验室资讯管理系统和集中式楼宇管理解决方案连接起来。这可以实现无缝资料流，并减轻品管团队的管理负担。

本报告概述了一种透明且稳健的调查方法，透过初步访谈、次要标准审查和三角验证，对生物安全柜的发展趋势进行了基于证据的评估。

本调查方法结合了多方面的证据基础和成熟的行业实践，对产品功能、买家偏好和供应链响应进行了全面评估。主要资讯来源包括对实验室管理人员、生物安全负责人、采购经理和现场服务技术人员的结构化访谈，以了解营运重点和决策标准。次要资讯来源则利用了同行评审的指导文件、国家和地区生物安全标准、製造商技术规范以及供应链信息，以确定产品性能和服务预期所处的背景。

结论总结了综合技术服务网路和供应链韧性如何重塑生物安全柜的采购和营运重点。

总而言之，生物安全柜环境正朝着以服务为中心的一体化解决方案发展，以支援法规遵循、营运连续性和实验室数位化。即时监控和模组化设计等技术进步为提高运作和更有效率的验证创造了机会。同时，贸易和供应链趋势也进一步凸显了区域服务体系和弹性筹资策略的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生物安全柜市场：依类别划分

  • 一级
  • 二类
    • A1
    • A2
    • B1
    • B2
  • 三级

第九章：生物安全柜市场：按类型划分

  • 水平的
  • 垂直的

第十章：生物安全柜市场：依最终用户划分

  • 学术和研究机构
  • 医院/临床检查室
  • 工业研发
  • 製药和生物技术

第十一章：生物安全柜市场：依应用领域划分

  • 细胞培养
  • 诊断
  • 微生物学
  • 药物测试

第十二章：生物安全柜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：生物安全柜市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：生物安全柜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国生物安全柜市场

第十六章：中国生物安全柜市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Air Science International, LLC
  • AirClean Systems, Inc.
  • AIRTECH Japan Ltd.
  • Berner International GmbH
  • Biolab Scientific Srl
  • CHC Biotech Co., Ltd.
  • Cruma SA
  • Donglian Har Instrument Co., Ltd.
  • Esco Micro Pte. Ltd.
  • EuroClone SpA
  • FASTER Srl
  • Germfree Laboratories, Inc.
  • Getinge AB
  • Heal Force Bio-Meditech Holdings Limited
  • Jinan Biobase Biotech Co., Ltd.
  • Labconco Corporation
  • LAMSYSTEMS CC
  • Mystaire Inc.
  • NuAire, Inc.
  • Shellab, Inc.
  • Suzhou Antai Airtech Co., Ltd.
  • Telstar, SL
  • The Baker Company, Inc.
  • Thermo Fisher Scientific Inc.
  • Yamato Scientific Co., Ltd.
Product Code: MRR-437D4595793A

The Biological Safety Cabinet Market was valued at USD 532.87 million in 2025 and is projected to grow to USD 574.68 million in 2026, with a CAGR of 8.87%, reaching USD 966.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 532.87 million
Estimated Year [2026] USD 574.68 million
Forecast Year [2032] USD 966.32 million
CAGR (%) 8.87%

A concise and authoritative introduction to current biological safety cabinet priorities spanning containment, compliance, and operational resilience across laboratory environments

Biological safety cabinets remain foundational infrastructure for laboratories performing work with infectious agents, cell culture, and sensitive diagnostic assays. Contemporary laboratories demand solutions that deliver consistent containment, user safety, and clean working conditions while enabling workflow efficiency and regulatory compliance. Advances in cabinet technology, such as improved airflow management, integrated monitoring, and materials designed for rigorous decontamination, are reshaping how facilities think about lifecycle costs and operational risk.

Stakeholders across academic research, clinical diagnostic operations, industrial research and development, and biopharmaceutical production are balancing competing priorities: the need to protect personnel and product integrity, the imperative to meet evolving regulatory and accreditation standards, and the pressure to optimize capital and operating expenditures. Decision makers are placing greater weight on equipment traceability, digital monitoring, and compatibility with laboratory information systems. Consequently, procurement strategies extend beyond purchase price to encompass serviceability, validation support, and long-term vendor partnerships, which is increasingly influencing procurement dialogues and vendor selection criteria.

How technological integration, regulatory tightening, and evolving laboratory practices are collectively redefining performance expectations and procurement criteria for biosafety cabinets

The landscape for biological safety cabinets is undergoing transformative shifts driven by technological innovation, regulatory evolution, and changing laboratory practices. New generations of cabinets incorporate sensor networks that provide real-time alerts for airflow deviations and filter performance, thereby enabling predictive maintenance and reducing unplanned downtime. This transition toward connected equipment is converging with laboratory digitization efforts, allowing facilities to integrate cabinet telemetry with environmental monitoring platforms and quality management systems.

Regulatory expectations and accreditation bodies are emphasizing standardized validation protocols and traceable records, prompting manufacturers to supply enhanced documentation and validation support. Additionally, workplace safety culture and heightened awareness of laboratory-acquired infections have elevated the priority of training and ergonomic design. As laboratories scale throughput and adopt more complex workflows, demand for configurable cabinet interiors and modular options has increased. These shifts collectively favor vendors that can demonstrate robust service networks, comprehensive training programs, and products designed for integration into modern laboratory ecosystems.

Quantifying the operational and procurement ripple effects of 2025 tariff adjustments in the United States on sourcing, inventory strategies, and supplier relationships for biosafety equipment

Tariff changes in the United States during 2025 introduced tangible implications for procurement strategies, supply chain design, and supplier negotiation dynamics for organizations acquiring biological safety cabinets and related components. Increased duties on specific imported goods amplified the total landed cost for units and spare parts sourced from affected regions, prompting procurement teams to revisit sourcing geographies and contractual terms. In response, a number of purchasers sought to renegotiate vendor agreements to include freight-in terms, extended warranty coverage, or bundled maintenance plans to mitigate the cost impact.

The tariff environment also accelerated conversations around regional sourcing and inventory buffering. Facilities with centralized procurement began exploring nearshoring alternatives or establishing multi-supplier strategies to maintain continuity of supply for critical consumables and replacement filters. At the same time, manufacturers responded by optimizing production footprints, qualifying alternate suppliers for critical components, and increasing transparency around origin labeling to help customers evaluate total cost implications. These adjustments illustrate how trade policy shifts can produce operationally focused responses across the value chain without changing the underlying regulatory and safety requirements that govern biosafety equipment.

Deep segmentation insights revealing how class, type, end user, and application interdependencies determine technical specifications procurement preferences and support needs

A granular view of segmentation reveals clear differentials in specification, procurement behavior, and support requirements across cabinet classes, types, end users, and applications. Based on Class, the landscape is studied across Class I, Class II, and Class III, with Class II further subdivided into A1, A2, B1, and B2, and each class imposes distinct containment, airflow, and exhaust requirements that shape installation and certification needs. Based on Type, cabinets are classified as Horizontal and Vertical designs, and the ergonomics, footprint, and workflow compatibility of these types influence user preference and laboratory layout decisions.

Based on End User, the customer base spans Academic & Research Institutes, Hospitals & Clinical Laboratories, Industrial R & D, and Pharmaceutical & Biotech, and each segment exhibits unique priorities: academic settings emphasize flexibility and cost-effective maintenance, clinical labs prioritize throughput and regulatory traceability, industrial R&D values modularity for diverse experimental workflows, and pharmaceutical and biotech customers demand stringent qualification packages and documented compliance support. Based on Application, common use-cases include Cell Culture, Diagnostics, Microbiology, and Pharmaceutical Testing, and the choice of cabinet is informed by contamination risk profiles, materials compatibility, and routine decontamination protocols. Understanding these intersecting segmentation dimensions enables product teams to align features, service offerings, and training packages to distinct buyer journeys while informing clinical engineers and facility planners on installation, validation, and long-term maintenance requirements.

Regional dynamics and service network strategies that influence procurement behavior and service expectations across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics shape supply chains, standards interpretation, and customer expectations in distinct ways. In the Americas, end users place heightened emphasis on service responsiveness, integration with clinical workflows, and alignment with federal and state safety regulations, which drives demand for local service networks and readily available consumables. In Europe, Middle East & Africa, a heterogeneous regulatory environment and a mix of resource settings have led suppliers to offer a wider spectrum of product configurations, flexible financing models, and comprehensive validation documentation to support diverse accreditation processes.

In Asia-Pacific, rapid expansion of research infrastructure, growing biopharma investment, and a rising number of clinical diagnostic facilities have increased focus on capacity expansion, local manufacturing partnerships, and scalable maintenance frameworks. Across all regions, localization of after-sales service and spare parts availability are primary determinants of buyer confidence; therefore, global suppliers are adapting by deploying regional service hubs, training local engineers, and tailoring documentation to regional regulatory expectations. These regional contrasts inform go-to-market strategies, pricing alignment, and service network investment decisions for manufacturers and distributors.

Key corporate and competitive intelligence demonstrating how service models product integration and lifecycle support drive buyer preference and vendor differentiation in biosafety solutions

Competitive positioning in the biosafety cabinet space increasingly hinges on service excellence, validation support, and product lifecycle management. Leading manufacturers and distributors differentiate through certified field service networks, digital service platforms that enable predictive maintenance scheduling, and comprehensive validation protocol packages that ease implementation for regulated customers. Strategic partnerships with filter manufacturers, sensor providers, and environmental monitoring platform vendors have enabled suppliers to offer integrated solutions rather than stand-alone equipment, thereby increasing stickiness with institutional customers.

Customer experience differentiators include rapid access to OEM replacement filters and parts, remote diagnostics capabilities, and structured training programs for laboratory personnel and biosafety officers. Service agreements that bundle periodic recertification, preventive maintenance, and on-site training are viewed favorably by organizations that must maintain continuous compliance and high uptime. Additionally, product roadmaps that incorporate modular upgrades, retrofit kits for legacy units, and compatibility with centralized monitoring systems help vendors maintain relevance across the installed base and support procurement strategies focused on long-term operational efficiency.

Actionable recommendations for manufacturers and institutional purchasers to strengthen service resilience integration and training while reducing total cost of ownership and compliance burden

Industry leaders can advance market leadership by prioritizing service resilience, interoperability, and customer education. Investing in regional service hubs and certified field technicians will reduce mean time to repair and enhance customer confidence in regulated environments. Equally important is the development of open integration frameworks and APIs that allow cabinet telemetry to connect with laboratory information management systems and centralized building management solutions, enabling seamless data flows and reducing administrative burden on quality teams.

Manufacturers should also expand training offerings that include virtual certification modules, on-site competency assessments, and documented qualification packages tailored to different end users. Strategic partnerships with local distributors and filter suppliers can mitigate tariff exposure and improve parts availability. Finally, adopting flexible commercial models-such as bundled service agreements, extended warranty packages, and retrofit options-will appeal to organizations seeking predictable operational budgets and simplified compliance pathways, thereby strengthening long-term vendor-customer relationships.

Transparent and robust research methodology outlining how primary interviews secondary standards review and triangulation produced an evidence-based assessment of biosafety cabinet dynamics

The research methodology combined a multi-source evidence base and validated industry practices to construct a comprehensive assessment of product capabilities, buyer preferences, and supply chain responses. Primary input included structured interviews with laboratory managers, biosafety officers, procurement leaders, and field service technicians to capture operational priorities and decision criteria. Secondary input comprised peer-reviewed guidance documents, national and regional biosafety standards, manufacturer technical specifications, and supply-chain intelligence to establish context for product performance and service expectations.

Data synthesis involved triangulating qualitative insights with documented certification protocols and vendor service offerings to identify consistent patterns in procurement behavior and technical requirements. The approach emphasized reproducibility of validation procedures, parity in comparative feature analysis, and careful attribution of regional regulatory influences. Where appropriate, sensitivity checks and cross-validation with field technicians and end users ensured that technical interpretations matched real-world operational constraints and maintenance practices.

Conclusion summarizing how integrated technology service networks and supply chain resilience are reshaping procurement and operational priorities for biosafety cabinets

In summary, the biological safety cabinet environment is evolving toward integrated, service-centric solutions that support regulatory compliance, operational continuity, and laboratory digitization. Technology enhancements such as real-time monitoring and modular design are creating opportunities for improved uptime and streamlined validation. Simultaneously, trade and supply chain dynamics have reinforced the importance of regional service capabilities and flexible sourcing strategies.

Decision makers should evaluate vendors not only on product specifications but also on documented validation support, spare parts logistics, and the ability to integrate cabinet telemetry into broader laboratory quality systems. Suppliers that combine rigorous technical performance with robust service ecosystems and clear documentation will be best positioned to meet the diverse needs of academic, clinical, industrial, and pharmaceutical users while navigating an increasingly complex procurement environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Safety Cabinet Market, by Class

  • 8.1. Class I
  • 8.2. Class II
    • 8.2.1. A1
    • 8.2.2. A2
    • 8.2.3. B1
    • 8.2.4. B2
  • 8.3. Class III

9. Biological Safety Cabinet Market, by Type

  • 9.1. Horizontal
  • 9.2. Vertical

10. Biological Safety Cabinet Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Hospitals & Clinical Laboratories
  • 10.3. Industrial R & D
  • 10.4. Pharmaceutical & Biotech

11. Biological Safety Cabinet Market, by Application

  • 11.1. Cell Culture
  • 11.2. Diagnostics
  • 11.3. Microbiology
  • 11.4. Pharmaceutical Testing

12. Biological Safety Cabinet Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biological Safety Cabinet Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biological Safety Cabinet Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biological Safety Cabinet Market

16. China Biological Safety Cabinet Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Air Science International, LLC
  • 17.6. AirClean Systems, Inc.
  • 17.7. AIRTECH Japan Ltd.
  • 17.8. Berner International GmbH
  • 17.9. Biolab Scientific S.r.l.
  • 17.10. CHC Biotech Co., Ltd.
  • 17.11. Cruma S.A.
  • 17.12. Donglian Har Instrument Co., Ltd.
  • 17.13. Esco Micro Pte. Ltd.
  • 17.14. EuroClone S.p.A.
  • 17.15. FASTER S.r.l.
  • 17.16. Germfree Laboratories, Inc.
  • 17.17. Getinge AB
  • 17.18. Heal Force Bio-Meditech Holdings Limited
  • 17.19. Jinan Biobase Biotech Co., Ltd.
  • 17.20. Labconco Corporation
  • 17.21. LAMSYSTEMS CC
  • 17.22. Mystaire Inc.
  • 17.23. NuAire, Inc.
  • 17.24. Shellab, Inc.
  • 17.25. Suzhou Antai Airtech Co., Ltd.
  • 17.26. Telstar, S.L.
  • 17.27. The Baker Company, Inc.
  • 17.28. Thermo Fisher Scientific Inc.
  • 17.29. Yamato Scientific Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 116. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 117. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 134. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 135. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 140. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 141. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)